Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Diagnosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06691776
What this trial is testing

Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)

Who this might be right for
Prostate CancerCervical CancerBladder Cancer+2 more
The Netherlands Cancer Institute 100
Not applicableUnknownNCT04661176
What this trial is testing

Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico

Who this might be right for
Prostate Cancer
miR Scientific LLC 500
Testing effectiveness (Phase 2)Looking for participantsNCT06616597
What this trial is testing

Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 58
Testing effectiveness (Phase 2)Study completedNCT02153918
What this trial is testing

Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy

Who this might be right for
Prostate CancerProstatic NeoplasmsNeoplasms, Prostate
National Cancer Institute (NCI) 27
Not applicableStudy completedNCT04789018
What this trial is testing

Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study

Who this might be right for
Prostate Carcinoma
Thomas Jefferson University 118
Testing effectiveness (Phase 2)Ended earlyNCT04423913
What this trial is testing

Safety, Tolerability, Distribution & Dose Effect of Neoadjuvant Transarterial Chemoembolization With Doxorubicin in Prostate Cancer Patients Before Radical Prostatectomy

Who this might be right for
Prostate Cancer
Centre Hospitalier Universitaire de Nīmes 12
Testing effectiveness (Phase 2)Ended earlyNCT00448097
What this trial is testing

Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy

Who this might be right for
Prostatic Neoplasms
The Methodist Hospital Research Institute 7
Testing effectiveness (Phase 2)Study completedNCT02023697
What this trial is testing

Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

Who this might be right for
Prostatic Neoplasms
Bayer 391
Testing effectiveness (Phase 2)Looking for participantsNCT06904313
What this trial is testing

Ultralow Dose PET Imaging for PSMA Expression

Who this might be right for
Healthy VolunteerProstate CA
Akiva Mintz 200
Not applicableStudy completedNCT03656822
What this trial is testing

Data Visualization of Kidney and Prostate Tumors Using Routine Pre-Operative Imaging, 3D Printed, and 3D Virtual Reality Models

Who this might be right for
Pleural Effusion
NYU Langone Health 303
Not applicableUnknownNCT04577222
What this trial is testing

The Ability of Adipose Flap Over the NVB to Improve Sexual and Urinary Function Following Radical Prostatectomy

Who this might be right for
Prostate CancerErectile DysfunctionUrinary Incontinence
Rabin Medical Center 60
Testing effectiveness (Phase 2)WithdrawnNCT04243941
What this trial is testing

PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT06765954
What this trial is testing

Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.

Who this might be right for
High-risk Prostate Cancer
ImmunityBio, Inc.
Large-scale testing (Phase 3)WithdrawnNCT00258466
What this trial is testing

Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Not applicableEnded earlyNCT01699672
What this trial is testing

Group-based or Individual Information About Disease and Treatment Plan

Who this might be right for
Prostate CancerBreast Cancer
Norwegian University of Science and Technology 98
Testing effectiveness (Phase 2)Study completedNCT00002602
What this trial is testing

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,084
Not applicableNot Yet RecruitingNCT07647445
What this trial is testing

Prostate MRI Analysis by Radiologists and Artificial Intelligence - Disease Identification and Guided Management

Who this might be right for
Prostate CA
University College, London 500
Post-approval studies (Phase 4)Study completedNCT02773251
What this trial is testing

The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity Surgery

Who this might be right for
Prostate CancerPostoperative Adhesion
Bucheon St. Mary's Hospital 60
Not applicableActive Not RecruitingNCT06995053
What this trial is testing

Computed Tomography-Guided Stereotactic Body Radiation Therapy With Intrafraction Motion Monitoring for the Treatment of Localized Prostate Cancer, ILLUSION Trial

Who this might be right for
Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 91
Not applicableUnknownNCT03284151
What this trial is testing

Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma

Who this might be right for
Prostate Cancer
Centre Francois Baclesse, Luxembourg 26
Next Page